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During the past several years, consumer-driven health (CDH) 
plans have started to grow rapidly. As of 2008, CDH plan 
enrollment was estimated to be as high as 12 million—an 
increase from 100,000 in 2002 (Greene, Hibbard, Murray, 
Teutsch, & Berger, 2008). The percentage of CDH plan 
enrollment out of total health plan enrollment also increased 
from 4% in 2006 to 8% in 2008; moreover, several states, 
including Florida and Idaho, had already begun to adopt CDH 
strategies in their Medicaid program (Greene, 2007). 
  
A CDH plan is a health insurance plan which combines high-
deductible insurance coverage with a personal health savings 
account such as a health savings account (HSA) or a health 
reimbursement arrangement (HRA). At first, CDH plan 
enrollees pay all their health care expenditures with funds 
from their health savings account. If health savings account 
funds are exhausted, they begin to pay with out-of-pocket 
funds before reaching the deductible limit. Once the 
deductible limit is met, coinsurance-based health insurance 
coverage begins. Although both HSAs and HRAs are tax-
exempt accounts, employers cannot have both in a single 
health plan. Typically, HSAs are funded by both employee and 
employer and are portable, which means employees can 
transfer the amount when they change jobs; however, HRAs 
are solely employer funded and not portable, thus they are 
forfeited by employer if employee leaves the employer. 
Furthermore, any unused balance remaining at year’s end can 
be rolled over to the next year in an HSA; therefore, the 
rationale for a CDH plan is to promote consumerism by 
providing consumers with discretionary management 
responsibility for their health care expenditures guided by a 
belief in consumer sovereignty (Sherman & Click, 2007). In 
other words, more cost-conscious employees under CDH 
plans would try to reduce unnecessary costs from unneeded 
medications and seek better care by using available 
information about quality, efficacy, and cost of treatments, 
which can ultimately lead to cost savings and improvement in 
quality of care.  
 
Historically, national attention to CDH care increased after 
enactment of the Medicare Prescription Drug Improvement 
and Modernization Act of 2003, which officially established 
tax-advantaged health savings accounts. This political success 
was spurred by libertarian conservatives who had interest in 
health care reimbursement accounts linked to high-
deductible coverage in the late 1990s when this new 
approach was very rare (Bloche, 2006). These conservatives 
formed an alliance with conservative activists, insurers, and 
financial institutions that supported this plan; together they 
persuaded the Bush administration to introduce this 
“consumer-directed” scheme in its agenda. Finally, the 
government decided to enact the law as a measure to reduce 
the continuously increasing cost of health care coverage. 
Since then, the health care paradigm seems to have shifted 
from managed care to consumer-driven health care. Prior to 
the advent of managed care plans, most employees joined 
health insurance plans where their portion of actual costs 
was determined by the plan selected and reimbursed 
approximately 80% of covered expenses (Nolin, & Killackey, 
2004). Under this plan, deductible and coinsurance were 
applied to medical spending before an annual out-of-pocket 
limit was reached. Once this limit was met, plans would cover 
100% of costs. After shifting to managed care, employers 
provided their employees with insurance plans through 
managed care organizations such as health maintenance 
organizations (HMOs) and preferred provider organizations 
(PPOs). Instead of deductible and coinsurance, copayment 
was applied under managed care plans; however, employers 
began to face difficulties as a result of significant increases in 
health care costs. Accordingly, employers have adopted a 
new plan where financial risks are shared with their 
employees, known as a CDH plan.   
 
Despite the increasing enrollment in CDH plans and trends of 
consumers’ deeper involvement of consumers in their health 
care, little empirical evidence exists of their impact on health 
care utilization. Therefore, this study examined early studies 
to determine whether CDH plan enrollment influenced a 
variety of outcomes, including changes in consumers’ health 
resource use, health care providers’ practice decisions, and 
total health care costs. Based on these findings, some 
suggestions were made to make the best use of CDH plans. 
Recognizing the potential of CDH care may guide health 
policy to better health outcomes in the future. 
 
First, empirical evidence suggests that CDH plans can lead to 
change in consumers’ health resource utilization, although 
whether the change is made in an appropriate manner in the 
long term remains to be seen. High-deductible and health 
savings accounts in CDH plans are likely to make their 
enrollees more cost-conscious and try to use health and cost 
information to make cost-saving, health-related decisions. 
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This conclusion is supported by research that compared the 
use of health-related information and health services by 
enrollees in a CDH plan with those in a PPO plan (Dixon, 
Greene, & Hibbard, 2008). It found that CDH plan enrollees 
were more likely to start using cost and health information 
and forgoing medical care than enrollees in other plans 
during 2003 to 2005. Specifically, they initiated use of 
information most actively shortly after enrolling in the CDH 
plan.  
 
In regard to the impact of CDH plans on hospitalizations and 
ER visits, findings have shown mixed results. Some found CDH 
plan enrollment was associated with reduction in ER visits 
and hospitalizations (Nair et al., 2009; Wharam et al., 2007). 
In a study by Wharam et al., emergency department visits 
among members who switched from a conventional plan to a 
CDH plan decreased by approximately 10%. The rate of 
hospitalization was also declined by 27% among them. Similar 
results were shown in a study conducted by Nair et al., where 
a reduction in the likelihood of any ER visit or hospitalization 
in the CDH plan group was more than two times greater than 
in the PPO plan group; however, this result is inconsistent 
with a study that suggested that CDH design did not 
discourage enrollees from consuming hospitalization 
(Parente, Feldman, & Christianson, 2004). This study found 
that CDH plan enrollees experienced significant annual 
increases in hospitalization rates during the study period 
(from 2000 to 2002), whereas increases in hospitalization 
rates for the other plans (HMO, PPO) were smaller. 
Accordingly, average hospital expenditures for CDH plan 
members increased dramatically, from about $1,370 in 2000 
to $3,470 in 2003. HMO and PPO plan members also faced a 
large increase in hospital expenditures (from $1,840 in 2000 
to $1,960 in 2002, and from $1,780 in 2000 to $ 2,370 in 
2002, HMO and PPO respectively), but the extent of the 
increase in both plans was not as substantial as that in CDH 
plans. This difference in effects on hospitalizations and ER 
visits in CDH plans may be because the health plan design is 
not so related to using this type of service. In other words, 
people may not care about their health plan when they need 
urgent and immediate treatment. In this case, they can visit 
emergency room and benefit from hospitalization regardless 
of their health plan. Alternatively, this difference may result 
from the different context in which these medical resources 
were used. The specific situations where subjects visited 
emergency department and used hospitalization were 
unknown in previous studies. For example, a decrease in ER 
visits in the previous study, conducted by Nair et al., may be 
due to a reduction in emergency conditions among CDH plan 
enrollees. Those who are in less serious condition may be less 
likely to visit the emergency room, resulting in a greater 
possibility of reducing the number of ER visits. Thus, as Nair 
et al. pointed out, it seems early yet to conclude that a 
change in ER visits and hospitalization is due to CDH plan 
design. To see whether CDH plans really affect hospitalization 
and ER visits in more detail, further research is needed on 
which division is experiencing decreased (or increased) 
number of visits, why they are decreasing (or increasing), 
how urgent the situation is when CDH plan enrollees use 
these resources, and how severe their symptoms are when 
they decide to be hospitalized.  
 
In addition, prescription drug use and medication adherence 
among CDH plan enrollees compared with those in other 
plans has been reported. Greene, Hibbard, Murray, Teutsch, 
and Berger (2008a) found that those who enrolled in a CDH 
plan tended to discontinue anti-hypertensives and lipid-
lowering drugs two to three times more than members in a 
PPO three-tier plan. Specifically, 17.4% of CDH plan members 
taking anti-hypertensives in 2003 stopped using them in 
2004, while only 5.6% of the PPO plan members discontinued 
use in 2004. In the case of lipid-lowering drugs, the percent 
discontinuing use was 16.6% among CDH plan enrollees, 
compared with 6.2% among PPO plan enrollees; however, 
CDH plan members did not adhere to their medication better 
than those in a PPO plan. Another study also showed that 
prescription utilization decreased by 31% among patients 
with chronic conditions after switching to a CDH plan (Nair et 
al., 2009). In this study, switching to a CDH plan also led to 
lower medication adherence in patients with chronic 
conditions. Possibly, this impact of CDH plans on prescription 
drug use and medication adherence is explained by the cost-
sharing structure under these plans; that is, members in a 
CDH plan are supposed to pay from their health savings 
account, which makes them more sensitive to purchasing 
prescription drugs. In this sense, the insurance plan design is 
more likely to affect enrollees’ manageable consumption 
behavior, such as prescription purchasing behavior, than their 
consumption patterns when they face unexpected situations 
requiring them to spend beyond their limit. If people need to 
spend a relatively large amount that is hard for them to 
control, they may care less about their spending, particularly 
in a situation where spending is used for emergency 
treatment; however, one concern is that this underutilization 
of prescription drugs among CDH plan enrollees might turn 
out to be inappropriate decisions based on imperfect 
knowledge and incomplete information, leading to severe 
morbidity and mortality in the future. Consumers who face 
higher cost sharing can reduce both essential and 
nonessential health services in an indiscriminate fashion, as 
seen from the RAND Health Insurance Experiment (1971-
1986) (Davis, 2004). This is one of the critics’ arguments 
against the promising consequences of CDH plans. Skeptics 
are concerned about whether discretionary decision-making 
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may discourage CDH plan enrollees from getting necessary 
medical care, because high-deductibles linked to CDH plans 
can induce them to purchase fewer medications. That is, CDH 
plan members may arbitrarily discontinue prescription drugs, 
which can result in more severe conditions later. 
Alternatively, they may switch to less-effective medications 
only because these medications are less costly, but they 
become less compliant or even experience adverse effects 
after switching medications; however, there has been no 
evidence showing that underutilization of prescription drugs 
among CDH plan enrollees actually led to adverse outcomes 
such as an increase in hospitalization, ICU admissions, or 
higher mortality. In addition, it is not clear whether CDH plan 
members will actually reduce both essential and non-
essential prescription purchases in an indiscriminate way as 
consumers who faced high cost-sharing did in the RAND 
experiment, because results from the RAND study may not be 
applicable today. Not only were the results obtained from the 
1970s to the middle of 1980s when medical circumstances 
available to consumers were quite different from the present, 
but recent consumers are also required to be more actively 
engaged in their health-related decisions than they used to 
be. Until now, CDH plans seemed somewhat new, yet with no 
firm conclusion about their long-term effect of prescription 
drug underutilization on future health outcomes. This 
suggests the importance of future research on the potential 
underutilization of essential health services and its long-term 
effects, because decisions should be based on long-term 
health and financial considerations rather than short-term 
cost savings.  
 
Little evidence exists on the effects of CDH plans on health 
care providers’ practice decisions on the use of health care 
resources. One of the reasons for insufficient reporting seems 
to be that CDH plans were initially offered merely as one of 
the health care plan options such as HMOs and PPOs to 
employees. Thus, only companies that provide these plans to 
employees and the vendors who offer health care plan 
products to companies have been involved in implementing 
CDH plans. Health care providers do not seem to have been 
incorporated into CDH plans directly and in-depth. This 
finding is supported by the fact that many primary care 
physicians report low knowledge and limited practice 
readiness regarding CDH plans (Mallya, Pollack, & Polsky, 
2008). In this study, 43% reported they had heard about CDH 
plans “a little” or “not at all” and approximately one-third 
reported they had low knowledge of how money is 
contributed and spent from a medical savings account. 
Nevertheless, one study showed that patient deductible level 
and socioeconomic status affect physician recommendations 
for preventive care (Pollack, Mallya, & Polsky, 2008). In this 
study, physicians’ recommendations for colorectal cancer 
screening varied depending on the patient’s coverage of 
preventive services and funds in medical savings accounts.  
 
The previous research about the impacts of CDH plans on 
health care spending has produced mixed results. One study 
suggested that it could create cost savings with relatively 
little negative effects on health (Bertko, 2004). Another study 
reviewed effects of CDH plans on costs and utilization and 
suggested that switching from a conventional plan to a CDH 
plan would result in 4% to 15% reduction in health care 
spending (Buntin et al., 2006). More recently, Parente et al. 
analyzed insurance claims and found that pharmaceutical 
expenditures were lower in CDH plans than in point-of-
service (POS) plans (Parente, Feldman, & Chen, 2008). This 
result was attributed to less generic use and more mail-order 
drug use among CDH plan enrollees despite no major 
differences in brand-name drug use between them and POS 
plan enrollees. In their previous research, those who had 
switched to a CDH plan had lower total health care 
expenditures than PPO enrollees (although their expenditures 
were higher than HMO enrollees) (Parente et al., 2004). 
Specifically, prescription drug expenditures and physician 
visits were the lowest among CDH plan enrollees, although 
hospital-based expenditures including hospitalizations were 
higher than other plans. In contrast to these findings, 
Feldman, Parente, and Christianson (2007) discovered that 
CDH plans had too little out-of-pocket cost-sharing to control 
health care spending (Feldman, Parente, & Christianson, 
2007; Parente et al., 2004). The study found that CDH plan 
enrollment was related to significantly higher hospital 
spending, although it found no direct evidence that reduced 
prescription drug use in CDH enrollees caused this higher 
hospital spending later. The critics also argue that CDH plan 
enrollees may have little impact on overall health care 
spending; that is, cost savings from CDH plan enrollees’ 
underutilization of health resources are too small to lower 
overall spending because most health care expenses occur 
with catastrophic or chronic conditions that exceed out-of-
pocket limits over which members have little control 
(Robinson, 2002). Again, CDH plan enrollees can lower what 
they can control, which accounts for a small part of total 
health care expenditures. This is countered by advocates of 
the CDH plan who argue that the purpose of CDH care is to 
engage consumers in their health management, thus 
preventing potential disease and reducing costs relevant to it. 
According to them, informed and educated consumers will 
lower the risks of getting chronic disease in particular, by 
involving themselves in early disease management. In 
conclusion, more evidence seems to be needed to show the 
effects of CDH plan on total health care spending, although 
CDH plan enrollees tend to reduce spending in purchasing 
prescription drugs.  
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Finally, some empirical data have shown the effects of CDH 
plan on the use of preventive and screening services. One 
study was conducted to compare the use of preventive and 
screening services among CDH plan enrollees with that 
among PPO plan enrollees (Rowe et al., 2008). It found no 
substantial differences in the use of such services as diabetes 
preventive services and cancer screening between these two 
groups. Another study also showed that switching a CDH plan 
was not associated with changes in breast, cervical, or 
colorectal screening compared with HMO enrollees, although 
CDH plan enrollees were more likely to replace expensive 
colonoscopy requiring high out-of-pocket spending with less 
expensive and fully covered screening tests (Wharam et al., 
2008). These results suggest that CDH plan members are not 
likely to underutilize preventive or screening services to any 
greater degree than those in other plans as long as they do 
not have higher out-of-pocket responsibility for these 
services.  
 
Considering all the issues, CDH plans are more likely to 
provide a supportive environment for enrollees to engage in 
health-related behaviors and manage their health. Overall, 
prescription drug use and its expenditures were lowered in 
CDH plan enrollees. Regarding utilization of hospital 
resources, the results were mixed. Some studies showed 
hospital-based spending was higher among CDH plan 
enrollees, whereas opposite results were found in other 
studies; however, research is lacking on whether 
underutilization of prescription drugs among CDH plan 
enrollees was clinically appropriate and whether higher 
hospitalization among them was caused by lagged treatments 
and reduced health services resulting from their discretionary 
decisions. To determine the long-term effects of CDH plans 
on overall health care spending, more empirical evidence is 
required.  
 
Based on empirical findings regarding the effects of CDH 
plans on diverse outcomes, several important implications 
can be stated. With CDH care comes a new era of 
consumerism, requiring an increasing role of consumers and 
engagement in managing their health care. Rising enrollment 
of CDH plans in private domain and starting to adopt CDH 
strategies in Medicaid (one of the public sectors) 
demonstrates this fact. Aside from CDH plans, consumers 
have already been affected by direct-to-consumer (DTC) 
advertising, and they have become proactive in making 
decisions concerning their health. Consumers seem to be 
increasingly engaged in making health-related decisions as 
more health information becomes available and they become 
more conscious of health care costs as a result of rising health 
care spending. This is supported by a study that showed CDH 
plan enrollees more likely to become engaged in behavioral 
change than HMO and POS plan members (Huskamp, & 
Rosenthal, 2009). However, it seems uncertain whether CDH 
plans can help lower health care expenditures. Cost savings 
from CDH care are likely to be too small to decrease overall 
health care expenditures, as noted earlier. However, even 
though CDH plans may have little impact on lowering health 
care spending, they have the potential for positive outcomes 
if they are used effectively and as intended. For example, if 
health care information is available to the public, it is 
expected to become more transparent. In particular, 
transparent information on health care costs and quality of 
care can motivate consumers to make more cost-effective 
decisions; thus, health care resources can be used more 
efficiently. Transparent information can also stimulate health 
care providers to improve the quality of services they deliver. 
They will provide health service based on quality rather than 
on profits if the information on quality of care is open to 
patients. In addition, if consumers are more engaged in 
managing their health, this awareness can promote health 
and reduce risk. It will save significant health care 
expenditures by preventing potential diseases on the 
condition that health is managed in an appropriate way to 
promote wellness. In this sense, consumers’ health 
management guided by professionals would prevent the 
potential dangers of self-diagnosis and inappropriate self-care 
based on imperfect knowledge and incomplete information. 
In particular, the recent increase in people with chronic 
conditions indicates the importance of self-management in 
health care.  
 
Aside from effects of CDH plans on overall health care 
spending, consumer engagement is meaningful itself in that it 
has great potential to produce beneficial outcomes, as shown 
previously. However, consumers alone cannot bring about 
these positive outcomes without such conditions as 
availability of information and guidance by professionals; 
therefore, joint efforts on the part of all relevant stakeholders 
are required. 
 
To make the best use of CDH care and achieve beneficial 
outcomes, some suggestions were made at both the social 
and individual levels.  
 
At the social level, an administrative policy that guarantees 
full coverage for preventive services without deductibles and 
copayments is required. There is concern that self-paying 
patients will skimp on high-benefit and low-cost preventive 
services (Bloche, 2007; Davis, 2004). At present, most 
insurers provide preventive services at no charge or before 
reaching the deductible in their CDH plans because they know 
they may be exposed to risk of large expenditures if patients 
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neglect prevention (Baicker, Dow, & Wolfson, 2007); 
nevertheless, prevention should be administratively ensured 
since the market cannot guarantee it. In addition, official 
information should be established and spread to consumers 
in a systematic, organized manner. Although the quantity of 
information has grown rapidly since the early 1990s when 
very little information was available because of resistance 
from drug manufacturers and medical specialty societies, 
consumers still seem confused about choosing and using the 
correct information because they are inundated with 
information (Arnold & Scanlon, 2009). An authorized 
institution (e.g., the Agency for Healthcare Research and 
Quality) can assess treatment options systematically, display 
clinical practice guidelines, and inform patients about 
treatment options and their expected outcomes in a 
coordinated way.  
 
At the individual level, more effort and involvement by 
employers, health care providers, and consumers are 
required comprehensively.  
 
First, employers should select a vendor sensibly; that is, the 
vendor should be strongly linked to the professional care 
providers in order to offer helpful health management 
programs to enrollees. The importance of selecting a vendor 
for successful CDH care is supported by the fact that it was 
considered one of the successful strategies used by early 
adopters of CDH (Sharon & Donahue, 2006). The purpose of 
CDH care is to engage consumers more in managing their 
own health and making better health care decisions using 
resources available to them; therefore, the quality of 
programs provided to consumers can be one of the key 
factors leading to successful CDH care. In this sense, if disease 
management programs based on the professional primary 
care providers can be integrated into CDH plans provided by 
the vendor, it can improve quality of care significantly; that is, 
managed care can be consolidated into CDH care. On-site 
managed clinics or pharmacies can also be included in the 
plan to deliver more professional-related care, as already 
shown in some CDH plans (Sharon & Donahue, 2006). This 
facilitates a strong relationship between the enrollees and 
professional care providers, which can result in more 
appropriate self-care by consumers with their help. In 
particular, chronic diseases (one of the major causes of 
morbidity and mortality) can be managed and controlled 
more effectively by a closer relationship between enrollees 
and the professional primary care providers. 
 
In well-selected programs, health care providers should play a 
more proactive role in assisting and educating consumers in 
managing their own health care and making better health 
care decisions. To participate in the program actively and 
help enrollees make better decisions, health care providers 
need to be more prepared. As mentioned, many primary care 
physicians may lack sufficient knowledge of and practice 
readiness for CDH plans (Mallya, Pollack, & Polsky, 2008). 
They need a better understanding of CDH plans, including 
cost sharing and personal savings accounts. In this sense, 
educational interventions by insurers or employers can be 
useful. After being equipped with requisite knowledge about 
CDH plans, health care providers can play crucial roles in 
aiding and educating consumers. In nursing practice, the 
importance of providers’ roles in a CDH care setting has 
already been reported (Nolin & Killackey, 2004; Sherman & 
Click, 2007). As Nolin et al. pointed out, health care providers’ 
responsibilities for educating consumers expand as 
consumers face more difficult and confusing choices in health 
care services and resources. Not only can they educate 
potential patients to promote health and prevent diseases, 
but they can also guide individuals with chronic diseases to 
optimal treatments through the programs.  
 
In addition, if consumers’ decisions were made with the 
support of health care providers who consider the economic, 
clinical, and humanistic aspects of CDH plans, it might provide 
the opportunity to save potential costs and bring positive 
health benefits to consumers. Actual evidence has been 
presented showing education of CDH plan enrollees 
increased lower-cost generic substitutions among those 
enrollees, although it had no influence on patients’ 
medication persistence (Sedjo & Cox, 2009). This evidence 
suggests that interventions in CDH plans can encourage 
enrollees to utilize more cost-effective alternatives. 
Accordingly, health care providers need to play a more active 
role in diverse educational programs incorporated into CDH 
plans.   
 
Finally, consumers should be motivated to be engaged in 
their health care decisions and in managing their health. 
Although CDH care assumes consumers’ direct involvement in 
their health care decisions, unfamiliarity with and difficulty 
understanding CDH plans is one of the challenges faced by 
consumers who are implementing such plans ("Consumer-
directed health plans," 2006; Greene, Peters, Mertz, & 
Hibbard, 2008b). A recent experimental study by Greene et 
al. showed that many consumers still had difficulty 
understanding CDH plan information and making informed 
health care choices. Results from this study also indicated 
when consumers were exposed to a presentation of plan 
information, their comprehension of the plan design was 
improved. Alternatively, some enrollees may not want to 
engage themselves in health care decisions. Therefore, plan 
providers should make a greater effort to inform employers 
and employees of such incentives for enrolling in CDH plans 
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as tax-favored accounts, rolling over unspent funds for use in 
future years, and fewer limits on provider choice compared 
with conventional health care plans. When the public agency 
provides trustworthy information to consumers and the 
program design allows consumers to interact with 
professional care providers, consumers will search for 
information, seek professionals’ advice, and play a more 
involved role in their health care decisions. We live in the era 
of consumerism; consumers need to recognize their active 
roles and participate in health care delivery. In the future, 
their roles in managing their own health care will be widely 
expanded. 
 
In conclusion, CDH care plans have been widely adopted since 
the early 2000s replacing conventional managed plans such 
as HMOs and PPOs. One of the reasons for such expansion of 
CDH plans is that employers faced with uncontrollable 
premium increases were willing to try this new plan to hold 
down costs. The potential benefit of a CDH plan is to raise 
consumer awareness of the real costs of care and to increase 
consumer involvement in their health care decisions, 
ultimately making consumers more cost-effective in their 
health care spending. Furthermore, consumers enrolled in 
CDH plans can be more flexible in selecting health care 
providers and services, which is expected to increase the 
quality of care they receive, whereas consumers who select 
them based mostly on the design of insurance plan in which 
they enroll among conventional managed care plans such as 
HMOs and PPOs may limit available choices of providers and 
types of services they can receive.   
 
Empirical evidence of the effectiveness of CDH plans is now 
being gathered. Based on previous findings, CDH plan 
enrollment is associated with a decrease in prescription drug 
use and accompanying expenditures, although it is not clear 
whether decrease in prescription drug use results in 
increased hospitalization and more severe morbidity in the 
future. Regarding the effects of CDH plans on hospital 
resource utilization, results seemed rather mixed. These 
findings suggest that CDH plan enrollees tend to reduce 
manageable spending such as prescription expenditures 
rather than uncontrollable larger spending in emergency 
situations. If consumers are not required to make higher out-
of-pocket payment for preventive and screening services, 
they are not likely to underutilize these services. Whether 
CDH care can result in cost containment and improve quality 
of care in the long term is still a question and remains to be 
seen. Furthermore, some have raised the question of 
disparity issues in care because CDH plans seem to attract 
healthy and wealthy people (Bloche, 2007; Barry et al., 2008). 
Differences in access and ability in using health-related 
information can increase disparity problems. Despite these 
uncertainties and concerns about a CDH plan, it has the 
potential for positive outcomes if it can be used as desired. 
For example, CDH plans can facilitate transparent information 
on health care costs and quality of care, contributing to 
consumers’ more cost-effective spending and improvement 
in quality of services delivered by health care providers. In 
addition, if consumers’ health is well-managed by the 
programs incorporated into a CDH plan, it will save costs by 
avoiding potential diseases and reducing risk factors in their 
health.  
 
To derive beneficial outputs from CDH care, further effort and 
collaboration by all stakeholders including consumers, health 
care providers, and policy makers are required. They should 
commit themselves to play their own roles and each part 
should be organically connected. That is, vendors should first 
link professionals such as primary care providers, 
pharmacists, and nurses to their programs and incorporate 
on-site managed clinics or pharmacies into CDH plans. Then, 
if employers select one of the vendors that provides these 
programs and services, CDH enrollees can interact with these 
professionals. Through interaction with professionals, 
enrollees can make better health care decisions and manage 
their own health more effectively. In other words, if CDH 
plans integrate health management programs linked to 
professionals or integrate on-site managed medical clinics or 
pharmacies into their plan design, more appropriate health 
management and better health care decisions guided by 
professional health care providers would be possible. This 
suggests that new CDH care should evolve into managed care 
linked to professionals incorporated into existing CDH care. 
That is, new CDH care has both CDH care and conventional 
managed care characteristics in that it allows active 
involvement by consumers in health-related decisions in the 
plan where professional primary care providers help them to 
decide. In addition, system-level interventions can prompt 
CDH care to function more effectively. For example, to 
prevent enrollees in high-deductible plans from skimping on 
preventive service, the service should be fully covered by CDH 
plans without copayments or deductibles. Furthermore, 
reliable health-related information by the authorized 
institution should be available to consumers, helping 
consumers make the most appropriate health decisions. 
 
CDH care has already been with us, and the trend requires a 
stronger role for consumers. More research is required on 
the most effective ways to engage consumers in their health 
care and on how consumers make their own decisions in real 
situations. Without understanding how they become engaged 
and make decisions in-depth, we cannot center consumers in 
the health care system. In the era of consumerism, engaged 
and activated consumers are assumed to find more optimal 
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and cost-effective treatments for themselves, to be better 
able to discontinue inappropriate or poor-quality care, and to 
manage their health better, resulting in better quality of care 
and cost savings. These assumptions are implicated in CDH 
care. If CDH care is considered merely one of the insurance 
plans with high-deductibles for sharing financial risks with 
enrollees without considering these implications, its value will 
be depreciated and it may be replaced by another type of 
insurance plan. In this sense, we should recognize the real 
meaning of CDH care and view CDH care as a measure to 
prompt consumers to care for their own health and actively 
engage in health management, thus helping them make the 
right health-related decisions, rather than viewing it as 
merely another type of health care plan option.  
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